Targeting of miR-31/96/182 to the Numb gene during head and neck oncogenesis

被引:20
|
作者
Chou, Chung-Hsien [1 ]
Tu, Hsi-Feng [2 ]
Kao, Shou-Yen [2 ,3 ]
Chiang, Chun-Yu Fan [1 ]
Liu, Chung-Ji [2 ,4 ]
Chang, Kuo-Wei [2 ,3 ]
Lin, Shu-Chun [1 ,3 ]
机构
[1] Natl Yang Ming Univ, Inst Oral Biol, Sch Dent, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan
[4] Taipei Mackay Mem Hosp, Dept Dent, Taipei, Taiwan
关键词
carcinoma; miR-31; miR-96; miR-182; mouth; Numb; SQUAMOUS-CELL CARCINOMA; CANCER STEM-CELLS; ORAL-CANCER; PROLIFERATION; EXPRESSION; RECEPTOR; PATHWAY; MIR-31; DIFFERENTIATION; TUMORIGENESIS;
D O I
10.1002/hed.25063
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundMicroRNAs (miRNAs) play crucial roles in head and neck squamous cell carcinoma (HNSCC). This study investigates whether miR-31, miR-96, and miR-182 are involved in targeting Numb during HNSCC. MethodsThe expression of miR-31/96/182 in tumor tissues was analyzed. Reporter assay, knockdown, expression, and oncogenic analysis were carried out in cell lines. ResultsUpregulation of miR-31/96/182 was detected in tumor tissues. In addition, advanced tumors showed higher expression levels of these miRNAs. The expression of these miRNAs was upregulated after treatment with areca ingredients (P<.01 or P<.001). These miRNAs directly targeted the 3 untranslated region (UTR) sequence of the Numb gene. An increased migration and invasion of HNSCC cells was associated with the exogenous expression of miR-31/96/182 (P<.01 or P<.001), and this was reverted by expression of Numb. ConclusionThis study provides new evidence demonstrating that there is frequent and concordant upregulation of miR-31, miR-96, and miR-182 during HNSCC and these miRNAs co-target Numb.
引用
收藏
页码:808 / 817
页数:10
相关论文
共 50 条
  • [1] MiR-31 is a potential biomarker for diagnosis of head and neck squamous cell carcinoma
    Wang, Long-Long
    Li, Hai-Xia
    Yang, Yong-Yan
    Su, Ya-La
    Lian, Jin-Shan
    Li, Teng
    Xu, Jie
    Wang, Xiao-Ning
    Jin, Na
    Liu, Xian-Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (09): : 4339 - 4345
  • [2] Targeting of multiple oncogenic miRNAs on NUMB gene to mediate head and neck carcinogenesis
    Ghou, Chung-Shan
    Chang, Kuo-Wei
    Lin, Shu-Chun
    CANCER RESEARCH, 2015, 75
  • [3] A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma
    Qiang, Hualong
    Zhan, Xiaodong
    Wang, Wei
    Cheng, Zhongqiang
    Ma, Shiyin
    Jiang, Chengyi
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (03) : 189 - 195
  • [4] Dietary Intake is Associated with miR-31 and miR-375 Expression in Patients with Head and Neck Squamous Cell Carcinoma
    Ferreira, Tathiany Jessica
    de Araujo, Caroline Castro
    Lima, Ana Carolina da Silva
    Matida, Larissa Morinaga
    Griebeler, Ana Flavia Mendes
    Coelho, Alexandre Siqueira Guedes
    Gontijo, Antonio Paulo Machado
    Cominetti, Cristiane
    Vencio, Eneida Franco
    Horst, Maria Aderuza
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (06): : 2049 - 2058
  • [5] Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis
    Hsieh, Yi-Ta
    Chen, Yi-Fen
    Lin, Shu-Chun
    Chang, Kuo-Wei
    Li, Wan-Chun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
  • [6] miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
    Lu, Wen-Cheng
    Liu, Chung-Ji
    Tu, Hsi-Feng
    Chung, Yu-Tung
    Yang, Cheng-Chieh
    Kao, Shou-Yen
    Chang, Kuo-Wei
    Lin, Shu-Chun
    ONCOTARGET, 2016, 7 (35) : 57254 - 57267
  • [7] miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma
    Liu, Chung-Ji
    Tsai, Meng-Miao
    Hung, Pei-Shih
    Kao, Shou-Yen
    Liu, Tsung-Yun
    Wu, Kou-Juey
    Chiou, Shih-Hwa
    Lin, Shu-Chun
    Chang, Kuo-Wei
    CANCER RESEARCH, 2010, 70 (04) : 1635 - 1644
  • [8] MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer
    Li, Maolan
    Chen, Wei
    Zhang, Hongchen
    Zhang, Yong
    Ke, Fayong
    Wu, Xiangsong
    Zhang, Yijian
    Weng, Mingzhe
    Liu, Yingbin
    Gong, Wei
    ONCOTARGET, 2016, 7 (50) : 83060 - 83070
  • [9] miR-31 controls osteoclast formation and bone resorption by targeting RhoA
    Mizoguchi, Fumitaka
    Murakami, Yousuke
    Saito, Tetsuya
    Miyasaka, Nobuyuki
    Kohsaka, Hitoshi
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [10] miR-31 controls osteoclast formation and bone resorption by targeting RhoA
    Fumitaka Mizoguchi
    Yousuke Murakami
    Tetsuya Saito
    Nobuyuki Miyasaka
    Hitoshi Kohsaka
    Arthritis Research & Therapy, 15